Preclinical characterization of AMPA receptor potentiator TAK‐137 as a therapeutic drug for schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical characterization of AMPA receptor potentiator TAK‐137 as a therapeutic drug for schizophrenia

Published:2019-05-09 Issue:3 Volume:7 Page:e00479
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Tanaka Maiko¹,Kunugi Akiyoshi¹,Suzuki Atsushi¹,Suzuki Noriko¹,Suzuki Motohisa¹,Kimura Haruhide¹^ORCID

Affiliation:

1. Neuroscience Drug Discovery Unit, ResearchTakeda Pharmaceutical Company Limited Fujisawa Japan

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.479

Reference69 articles.

1. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

2. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

3. All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

4. Psychosis pathways converge via D2High dopamine receptors

5. The NIMH-CATIE Schizophrenia Study: What Did We Learn?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Effects of Aripiprazole on Electroencephalography-Recorded Gamma-Band Auditory Steady-State Response, Spontaneous Gamma Oscillations and Behavior in a Schizophrenia Rat Model;International Journal of Molecular Sciences;2024-01-14

2. Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant;Neuropharmacology;2023-01

3. Diversity of AMPA Receptor Ligands: Chemotypes, Binding Modes, Mechanisms of Action, and Therapeutic Effects;Biomolecules;2022-12-27

4. Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia;Behavioural Pharmacology;2022-09-12

5. Cerebellar glutamatergic system impacts spontaneous motor recovery by regulating Gria1 expression;npj Regenerative Medicine;2022-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3